Polyphony: superposition independent methods for ensemble-based drug discovery
暂无分享,去创建一个
[1] Charlotte M. Deane,et al. JOY: protein sequence-structure representation and analysis , 1998, Bioinform..
[2] Giulio Superti-Furga,et al. Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation , 2001, Cell.
[3] P. Radivojac,et al. Improved amino acid flexibility parameters , 2003, Protein science : a publication of the Protein Society.
[4] L. Johnson,et al. Effects of Phosphorylation of Threonine 160 on Cyclin-dependent Kinase 2 Structure and Activity* , 1999, The Journal of Biological Chemistry.
[5] Tom L. Blundell,et al. Comprehensive, atomic-level characterization of structurally characterized protein-protein interactions: the PICCOLO database , 2011, BMC Bioinformatics.
[6] Z. Deng,et al. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.
[7] L. Johnson,et al. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. , 2001, Molecular cell.
[8] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[9] Hua Tang,et al. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases. , 2011, ACS chemical biology.
[10] Roland L. Dunbrack,et al. A new clustering of antibody CDR loop conformations. , 2011, Journal of molecular biology.
[11] X. Barril,et al. Incorporating protein flexibility into docking and structure-based drug design , 2006, Expert opinion on drug discovery.
[12] L. Johnson. Protein kinase inhibitors: contributions from structure to clinical compounds , 2009, Quarterly Reviews of Biophysics.
[13] S. Rackovsky,et al. Differential Geometry and Polymer Conformation. 1. Comparison of Protein Conformations1a,b , 1978 .
[14] Gisbert Schneider,et al. Virtual screening: an endless staircase? , 2010, Nature Reviews Drug Discovery.
[15] Susan S. Taylor,et al. Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.
[16] Jaroslav Koca,et al. Functional flexibility of human cyclin‐dependent kinase‐2 and its evolutionary conservation , 2007, Protein science : a publication of the Protein Society.
[17] S. Blackshaw,et al. Profiling the Human Protein-DNA Interactome Reveals ERK2 as a Transcriptional Repressor of Interferon Signaling , 2009, Cell.
[18] J B Findlay,et al. Protein dynamics derived from clusters of crystal structures. , 1997, Biophysical journal.
[19] Royston Goodacre,et al. BIOINFORMATICS APPLICATIONS NOTE , 2006 .
[20] A. Liwo,et al. Computational techniques for efficient conformational sampling of proteins. , 2008, Current opinion in structural biology.
[21] I. Bahar,et al. Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Goldsmith,et al. Mutations in ERK2 Binding Sites Affect Nuclear Entry* , 2007, Journal of Biological Chemistry.
[23] Geoffrey J. Barton,et al. Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..
[24] Brian E. Granger,et al. IPython: A System for Interactive Scientific Computing , 2007, Computing in Science & Engineering.
[25] Nicholas Furnham,et al. Comparative modelling by restraint-based conformational sampling , 2008, BMC Structural Biology.
[26] Holger Gohlke,et al. Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.
[27] T. Gregory Dewey,et al. Structure alignment based on coding of local geometric measures , 2006, BMC Bioinformatics.
[28] John A Tainer,et al. Crystal Structure and Mutational Analysis of the Human CDK2 Kinase Complex with Cell Cycle–Regulatory Protein CksHs1 , 1996, Cell.
[29] X. Barril,et al. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. , 2010, Journal of medicinal chemistry.
[30] C. Chothia,et al. The structure of protein-protein recognition sites. , 1990, The Journal of biological chemistry.
[31] P. Nguyen,et al. Energy landscape of a small peptide revealed by dihedral angle principal component analysis , 2004, Proteins.
[32] Heather A Carlson,et al. Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.
[33] Michelle R. Arkin,et al. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.
[34] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[35] C. Sander,et al. Correlated mutations and residue contacts in proteins , 1994, Proteins.
[36] G Eisenbrand,et al. Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate. , 2001, Structure.
[37] L. Johnson,et al. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.
[38] Modesto Orozco,et al. MoDEL (Molecular Dynamics Extended Library): a database of atomistic molecular dynamics trajectories. , 2010, Structure.
[39] P. Jeffrey,et al. Structural basis of cyclin-dependent kinase activation by phosphorylation , 1996, Nature Structural Biology.
[40] Elfi Kraka,et al. !"#c%&'(&)* ,*-."c)/*&(&)* )0 ."/12,% ,*-!()%("- 3"c)*-,%4 3(%1c(1%"# &* 5%)("&*# 6#&*/ (h" 81()9,("-5%)("&* 3(%1c(1%" 8*,24# :"(h)- 1= Introduction , 2022 .
[41] J. Duca,et al. Recent advances on structure-informed drug discovery of cyclin-dependent kinase-2 inhibitors. , 2009, Future medicinal chemistry.
[42] H. Berendsen,et al. Essential dynamics of proteins , 1993, Proteins.
[43] P. Røgen,et al. Automatic classification of protein structure by using Gauss integrals , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[44] Mark A. Williams,et al. Visualisation of variable binding pockets on protein surfaces by probabilistic analysis of related structure sets , 2011, BMC Bioinformatics.
[45] N. Pavletich. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. , 1999, Journal of molecular biology.
[46] R. Abseher,et al. Essential spaces defined by NMR structure ensembles and molecular dynamics simulation show significant overlap , 1998, Proteins.
[47] L. Johnson,et al. The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2‐independent roles , 2005, The EMBO journal.
[48] Joaquín Dopazo,et al. ETE: a python Environment for Tree Exploration , 2010, BMC Bioinformatics.
[49] Adam Godzik,et al. FATCAT: a web server for flexible structure comparison and structure similarity searching , 2004, Nucleic Acids Res..
[50] Elfi Kraka,et al. Classification of Supersecondary Structures in Proteins Using the Automated Protein Structure Analysis Method , 2008, 0811.3464.
[51] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[52] G. Vriend,et al. Prediction of protein conformational freedom from distance constraints , 1997, Proteins.
[53] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[54] S. Kim,et al. High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design. , 1996, Journal of medicinal chemistry.
[55] Charles A. Laughton,et al. A Study of CDK2 Inhibitors Using a Novel 3D‐QSAR Method Exploiting Receptor Flexibility , 2009 .
[56] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[57] X. Barril,et al. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.
[58] John D. Hunter,et al. Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.
[59] Olivier Sperandio,et al. How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis , 2010, European Biophysics Journal.
[60] Amedeo Caflisch,et al. Wordom: a program for efficient analysis of molecular dynamics simulations , 2007, Bioinform..
[61] John Harris,et al. Handbook of mathematics and computational science , 1998 .
[62] Arthur J. Olson,et al. p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses. , 2009, Journal of molecular biology.
[63] Leo S. D. Caves,et al. Bio3d: An R Package , 2022 .
[64] M. E. M. Noble,et al. The structure of CDK4/cyclin D3 has implications for models of CDK activation , 2009, Proceedings of the National Academy of Sciences.
[65] John P. Overington,et al. HOMSTRAD: A database of protein structure alignments for homologous families , 1998, Protein science : a publication of the Protein Society.
[66] Federico Gago,et al. Overcoming the Inadequacies or Limitations of Experimental Structures as Drug Targets by Using Computational Modeling Tools and Molecular Dynamics Simulations , 2007, ChemMedChem.
[67] Corrado Loglisci,et al. Computational annotation of UTR cis-regulatory modules through Frequent Pattern Mining , 2009, BMC Bioinformatics.
[68] Stephen K Burley,et al. Rapid-access, high-throughput synchrotron crystallography for drug discovery. , 2012, Trends in pharmacological sciences.
[69] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] BMC Bioinformatics , 2005 .
[71] Tom L. Blundell,et al. CREDO: a structural interactomics database for drug discovery , 2013, Database J. Biol. Databases Curation.
[72] Peter M Fischer,et al. Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design. , 2006, Chemistry & biology.
[73] Vincent Le Guilloux,et al. Fpocket: An open source platform for ligand pocket detection , 2009, BMC Bioinformatics.
[74] Anton Nekrutenko,et al. Rapid and asymmetric divergence of duplicate genes in the human gene coexpression network , 2006, BMC Bioinformatics.
[75] Emma Lees,et al. Structure-guided discovery of cyclin-dependent kinase inhibitors. , 2008, Biopolymers.
[76] Yuzhu Chen,et al. N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2. , 2004, Journal of medicinal chemistry.
[77] E. Goldsmith,et al. Structural basis of inhibitor selectivity in MAP kinases. , 1998, Structure.
[78] B. X. Carlson,et al. A single glycine residue at the entrance to the first membrane-spanning domain of the gamma-aminobutyric acid type A receptor beta(2) subunit affects allosteric sensitivity to GABA and anesthetics. , 2000, Molecular pharmacology.
[79] Adrian H Elcock,et al. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase. , 2006, Journal of molecular biology.
[80] Tom Blundell,et al. CREDO: A Protein–Ligand Interaction Database for Drug Discovery , 2009, Chemical biology & drug design.
[81] L. Tong,et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002, Nature Structural Biology.
[82] Bartek Wilczynski,et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..
[83] Michele Vendruscolo,et al. ARABESQUE: A TOOL FOR PROTEIN STRUCTURAL COMPARISON USING DIFFERENTIAL GEOMETRY AND KNOT THEORY , 2012 .
[84] T F Havel,et al. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X‐ray structures , 1992, Protein science : a publication of the Protein Society.
[85] Travis E. Oliphant,et al. Scientific Computing with Python , 2004 .
[86] Steven Hayward,et al. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50. , 2002, Journal of molecular graphics & modelling.
[87] Mark Gerstein,et al. MolMovDB: analysis and visualization of conformational change and structural flexibility , 2003, Nucleic Acids Res..
[88] Manfredo P. do Carmo,et al. Differential geometry of curves and surfaces , 1976 .
[89] M. DePristo,et al. Relation between native ensembles and experimental structures of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[90] Kornelia Polyak,et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex , 1995, Nature.
[91] Tom L. Blundell,et al. CHORAL: a differential geometry approach to the prediction of the cores of protein structures , 2005, Bioinform..
[92] Thomas Lengauer,et al. Conformational analysis of alternative protein structures , 2007, Bioinform..
[93] H. Wolfson,et al. Flexible protein alignment and hinge detection , 2002, Proteins.
[94] Benjamin A Hall,et al. Dynamite: a simple way to gain insight into protein motions. , 2004, Acta crystallographica. Section D, Biological crystallography.
[95] D. M. Jacobsen,et al. Briefly bound to activate: transient binding of a second catalytic magnesium activates the structure and dynamics of CDK2 kinase for catalysis. , 2011, Structure.
[96] Ivet Bahar,et al. ProDy: Protein Dynamics Inferred from Theory and Experiments , 2011, Bioinform..
[97] Martin E M Noble,et al. Molecular Motions of Human Cyclin-dependent Kinase 2* , 2005, Journal of Biological Chemistry.
[98] Huijong Han,et al. Discovery of a potential allosteric ligand binding site in CDK2. , 2011, ACS chemical biology.
[99] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[100] J. Wells,et al. Searching for new allosteric sites in enzymes. , 2004, Current opinion in structural biology.